Androgen receptor (AR)
Assets acting on this target.
- Class
- Oral testosterone undecanoate
- Notes
- verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/study/NCT04134091
Related mechanisms
Assets acting on this target.
Related mechanisms
1 of 1 assets